Holen Sie sich die Stockscreener-App
7.08
8.83%
0.5744
Finanzdaten der Tevogen Bio Holdings Inc-Aktie (TVGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
4.84%
5.6624
|
5.4009 | 4.6102 | 5.7294 | 5.4445 |
| Operating Income/Loss |
4.84%
-5.6624
|
-5.4009 | -4.6102 | -5.7294 | -5.4445 |
| Net Interest Income/Expense |
38.25%
-0.0984
|
-0.0712 | -0.0707 | -0.0623 | -0.038 |
Net Income/Loss
|
5.80%
-5.7619
|
-5.4463 | -4.6776 | -5.7268 | -5.504 |
| Basic Average Shares |
9.84%
3.8294
|
3.4862 | - | 196.03 | 184.31 |
| Diluted Average Shares |
9.84%
3.8294
|
3.4862 | - | 196.03 | 184.31 |
| Basic Earnings Per Share |
5.59%
-1.52
|
-1.61 | - | -0.03 | -0.03 |
| Diluted Earnings Per Share |
5.59%
-1.52
|
-1.61 | - | -0.03 | -0.03 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):